Michael Kaminer
Dermatology · Chestnut Hill, MANPI 1568424042
Payments from drug & device makers
What this record shows
This record is dominated by other: $748,787 of the $1,050,382 with a category attached, or 71.3%. AbbVie accounts for 80.8% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2021 at $771,385 and has fallen 98.1% since, to $14,765 in 2025. Among dermatology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 241 payments — averaging $4358.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$849K
- Evolved By Nature, Inc.$145K
- Solta Medical, A Division Of Bausch Health US, LLC$44K
- Galderma Laboratories, L.p.$5K
- Endo Pharmaceuticals Inc.$4K
- LEO Pharma Inc.$356
- plus $3K from 17 others
Across 18 payments — averaging $4456.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Endo Pharmaceuticals Inc.$69K
- Bausch Health US, LLC$11K
What the payments were for
- Consulting fees$287,38627%
- Speaking & faculty fees$1,8500%
- Travel & lodging$6,6431%
- Food & beverage$5,7001%
- Education$160%
- Other$748,78771%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 74 | $848,692 |
| Evolved By Nature, Inc. | 8 | $145,278 |
| Solta Medical, A Division Of Bausch Health US, LLC | 10 | $43,784 |
| Galderma Laboratories, L.p. | 12 | $5,027 |
| Endo Pharmaceuticals Inc. | 7 | $4,449 |
| LEO Pharma Inc. | 15 | $356 |
| Amgen | 13 | $342 |
| UCB, Inc. | 12 | $320 |
| Novartis | 13 | $266 |
| Lilly USA, LLC | 11 | $250 |
| E.r. Squibb & Sons, L.L.C. | 8 | $218 |
| Sun Pharmaceutical Industries Inc. | 9 | $210 |
| Johnson & Johnson | 10 | $210 |
| Incyte Corporation | 8 | $191 |
| Revance Therapeutics, Inc. | 4 | $180 |
| Regeneron Healthcare Solutions, Inc. | 8 | $171 |
| Sanofi | 5 | $128 |
| Boehringer Ingelheim | 3 | $74 |
| Genentech USA, Inc. | 3 | $59 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $55 |
| Pfizer | 2 | $51 |
| Arcutis Biotherapeutics, Inc. | 2 | $36 |
| Organon | 1 | $35 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$230
How this compares
$1,050,382 in reported general payments places this provider in the 95th percentile of 552 dermatology providers in Massachusetts.
Other dermatology in Chestnut Hill
- Jeffrey SobellChestnut Hill$986K
- Jeffrey DoverChestnut Hill$200K
- Brooke SikoraChestnut Hill$23K
- John HarrisWorcester$15M
- Ethan LernerCharlestown$1.7M
- Erik DominguesFall River$736K
- Alexandra KimballBoston$680K
- Arash MostaghimiBoston$591K
- David GreensteinBeverly$540K
- Brian HiblerBoston$498K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.